HIMS Stock Faces Dual Blow From Expanded FTC Privacy Lawsuit After Selloff Driven By Q3 Subscriber Loss

What happened

The Federal Trade Commission filed an amended complaint against Hims & Hers Health, adding Arizona, Florida, Nebraska, Ohio, and Wisconsin as co-plaintiffs. Regulators allege the company shared sensitive health data with advertising platforms, charged for prescriptions before provider consultations, and made subscriptions hard to cancel; the company has called the allegations baseless.

Confirmed

Global impact / market context

The added states expand the group bringing the privacy and subscription claims, increasing regulatory pressure while the case proceeds. If the allegations are upheld, legal costs or changes to data use, prescription sales, and cancellation processes could raise expenses or constrain how Hims & Hers attracts and serves customers.

Analyst inference

The article links the lawsuit to a disappointing earnings report, but provides no detail on the financial impact of the claims. If the case leads to added legal or compliance costs, those expenses could reduce cash available for investment or growth.

Analyst inference

What to watch

1. The amended complaint is pending in federal court; the article says the company’s motion to dismiss is set for a January 7 hearing. Confirmed
2. Watch whether the court allows the complaint to proceed, since continued litigation could require spending on legal defense and potentially changing customer-data or subscription practices. Analyst inference
3. The article says the company had called the claims baseless; watch for its response to the amended complaint and any disclosed effect on operations or spending. Confirmed

Evidence

• stocktwits.com